Use of convalescent plasma in hospitalized patients with COVID-19: case series

Two case series examining the impact of convalescent plasma on patients with COVID-19 suggest some clinical benefit from early administration and modest impact on parameters of inflammation. Further assessment of the impact of this intervention awaits controlled clinical trials.

Detalles Bibliográficos
Autores principales: Hegerova, Livia, Gooley, Ted A., Sweerus, Kelly A., Maree, Cynthia, Bailey, Neil, Bailey, Megumi, Dunleavy, Vanessa, Patel, Krish, Alcorn, Kirsten, Haley, Rebecca, Johnsen, Jill M., Konkle, Barbara A., Lahti, Annamarie C., Alexander, Morgan L., Goldman, Jason D., Lipke, Anne, Lim, Sun-jung, Sullivan, Mark D., Pauk, John S., Pagel, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Letter to Blood
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414587/
https://www.ncbi.nlm.nih.gov/pubmed/32559767
http://dx.doi.org/10.1182/blood.2020006964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414587/
https://www.ncbi.nlm.nih.gov/pubmed/32559767
http://dx.doi.org/10.1182/blood.2020006964

Ejemplares similares